SCHEMBL2021933

SCHEMBL2021933

[SeH]c1c([SeH])c([SeH])c2c(c1[SeH])Oc1c([SeH])c([SeH])c([SeH])c([SeH])c1C2c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.39
ABL1 P00519 1/20 0.37
RIN1 Q13671 1/20 0.37
CYP1A2 P05177 3/20 0.33
LMNA P02545 2/20 0.33
CYP3A4 P08684 2/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
HTR2B P41595 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
ALDH1A1 P00352 1/20 0.32
GFER P55789 1/20 0.32
CYP2C19 P33261 5/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
CFTR P13569 1/20 0.31
GOPC Q9HD26 1/20 0.31
TSHR P16473 1/20 0.31
SLC6A2 P23975 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3278459 0.65 ALOX5 (0.51) IDO1ABL1RIN1LMNAMAPT
SCHEMBL21971755 0.62 KDM1A (0.40) IDO1ABL1RIN1CYP1A2CYP3A4
SCHEMBL10707636 0.60 MAPT (0.52) IDO1ABL1RIN1CYP1A2LMNA
SCHEMBL21971699 0.58 KDM1A (0.33) IDO1MAPTMAPK1NPSR1CFTR
SCHEMBL7918631 0.57 CYP1A2 (0.48) ABL1CYP1A2LMNACYP3A4TP53
SCHEMBL65759 0.57
SCHEMBL28347963 0.57 LMNA (0.39) IDO1CYP1A2LMNACYP3A4TP53
SCHEMBL40368 0.57 CYP2C9 (0.55) CYP1A2LMNACYP3A4TP53MAPT
SCHEMBL13356510 0.55 MEN1 (0.48) LMNAHTR2BCYP2C19MEN1KMT2A
Ammonia Solution, Strong SCHEMBL27131584 0.55 CYP1A2 (0.46) ABL1CYP1A2LMNACYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328885-A1 Alpha-CRYSTALLINE FORM OF SUBSTITUTED SELENOXANTHENES AND THE METHOD OF ITS PREPARATION Medbiopharm Ltd (RU) 2011-06-08 EP disclosed
WO-2009115892-A1 α-CRYSTALLINE FORM OF SUBSTITUTED SELENOXANTHENES AND THE METHOD OF ITS PREPARATION MEDBIOPHARM LTD (RU) 2009-09-24 WO disclosed